Canada Sepsis Therapeutic Market Size & Outlook, 2025-2030
The sepsis therapeutic market in Canada is expected to reach a projected revenue of US$ 194.9 million by 2030. A compound annual growth rate of 7.2% is expected of Canada sepsis therapeutic market from 2025 to 2030.
Revenue, 2024 (US$M)
$128.8
Forecast, 2030 (US$M)
$194.9
CAGR, 2025 - 2030
7.2%
Report Coverage
Canada
Related Markets
Canada sepsis therapeutic market highlights
- The Canada sepsis therapeutic market generated a revenue of USD 128.8 million in 2024 and is expected to reach USD 194.9 million by 2030.
- The Canada market is expected to grow at a CAGR of 7.2% from 2025 to 2030.
- In terms of segment, cephalosporin was the largest revenue generating drug class in 2024.
- Glycopeptide is the most lucrative drug class segment registering the fastest growth during the forecast period.
Sepsis therapeutic market data book summary
| Market revenue in 2024 | USD 128.8 million |
| Market revenue in 2030 | USD 194.9 million |
| Growth rate | 7.2% (CAGR from 2025 to 2030) |
| Largest segment | Cephalosporin |
| Fastest growing segment | Glycopeptide |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cephalosporin, Aminoglycosides, Glycopeptide, Other Drug Class |
Other key industry trends
- In terms of revenue, Canada accounted for 3.3% of the global sepsis therapeutic market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. sepsis therapeutic market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in North America and is projected to reach USD 36.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Sepsis Therapeutic Market Scope
Sepsis therapeutic market segmentation & scope
Sepsis Therapeutic Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| InflaRx | View profile | 11-50 | Jena, Thuringen, Germany, Europe | https://www.inflarx.de/ |
| Aridis Pharmaceuticals | View profile | 11-50 | San Jose, California, United States, North America | http://aridispharma.com/ |
| Eli Lilly and Company | View profile | - | - | - |
| GSK plc | View profile | - | - | - |
| La jolla Pharmaceutical | View profile | 101-250 | San Diego, California, United States, North America | https://www.lajollapharmaceutical.com |
| T2 Biosystems Inc | View profile | 113 | 101 Hartwell Avenue, Lexington, MA, United States, 02421 | https://www.t2biosystems.com |
| Astellas Pharma Inc | View profile | 14484 | 2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, Japan, 103-8411 | http://www.astellas.com |
| GSK PLC ADR | View profile | 70200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | https://www.gsk.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
Canada Drug Class - Sepsis Therapeutic Market size, 2024 - 2030 (US$M)
Canada Sepsis Therapeutic Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
